Literature DB >> 12108920

Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.

T Ravingerová1, D Pancza, A Ziegelhoffer, J Styk.   

Abstract

A new concept of cardioprotection based on the exploitation of endogenous mechanisms is known as ischemic preconditioning (IPC). It has been hypothesized that substances released during brief ischemic stress (e.g. catecholamines) stimulate the receptors and trigger multiple cell signaling cascades. Opening of ATP-sensitive K+ channels [K(ATP)] has been suggested as a possible final step in the mechanisms of protection. In this study, the role of adrenergic activation was tested in Langendorff-perfused rat hearts subjected to test ischemia (TI; 30 min occlusion of LAD coronary artery) by: 1) mimicking IPC (5 min ischemia, 10 min reperfusion) with short-term (5 min) administration of norepinephrine (NE, 1 microM), 15 min prior to TI; 2) blockade with beta- or alpha1-receptor antagonists, propranolol (10 microM) and prazosin (2 microM), respectively, applied 15 min prior to TI during IPC. The role of K(ATP) opening was examined by perfusion with a K(ATP) blocker glibenclamide (10 microM) during IPC. Both IPC and NE-induced PC effectively reduced the incidence of ventricular tachycardia (VT) to 33% and 37%, respectively, vs 100% in the non-PC controls, whereby ventricular fibrillation (VF) was totally abolished by IPC and markedly suppressed by PC with NE (0% and 10%, respectively, vs 70% in the non-PC hearts; P < 0.05). The severity of arrhythmias (arrhythmia score, AS) was also markedly attenuated by both interventions (IPC: AS 1.7 +/- 0.4; NE-PC: AS 1.8 +/- 0.3 vs AS 4.1 +/- 0.2 in the controls; P < 0.05). Protection was not suppressed by propranolol (VT 28%; VF 14%; AS 2.2 +/- 0.6), whereas prazosin reversed the protective effect of PC (VT 83%; VF 67%; AS 4.0 +/- 0.8). Antiarrhythmic protection afforded by NE-PC was abolished by pretreatment of rats with pertussis toxin (25 microg/kg, i.p.) given 48 h prior to the experiments. Glibenclamide did not suppress the IPC-induced protection. In conclusion, the sensitivity of the rat heart to ischemic arrhythmias can be modulated by IPC. Protection is mediated via stimulation of alpha1-adrenergic receptors coupled with Gi-proteins but glibenclamide-sensitive K(ATP) channels do not appear to be involved in the mechanisms of antiarrhythmic protection in this model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12108920

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  16 in total

1.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress.

Authors:  T Ravingerová; I Bernátová; J Matejíková; V Ledvényiová; M Nemčeková; O Pecháňová; N Tribulová; J Slezák
Journal:  Exp Clin Cardiol       Date:  2011

2.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Postconditioning with α7nAChR agonist attenuates systemic inflammatory response to myocardial ischemia--reperfusion injury in rats.

Authors:  Jun Xiong; Yu-Jing Yuan; Fu-Shan Xue; Qiang Wang; Yi Cheng; Rui-Ping Li; Xu Liao; Jian-Hua Liu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Postconditioning with vagal stimulation attenuates local and systemic inflammatory responses to myocardial ischemia reperfusion injury in rats.

Authors:  Qiang Wang; Yi Cheng; Fu-Shan Xue; Yu-Jing Yuan; Jun Xiong; Rui-Ping Li; Xu Liao; Jian-Hua Liu
Journal:  Inflamm Res       Date:  2012-07-24       Impact factor: 4.575

5.  Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia-reperfusion injury.

Authors:  Jun Xiong; Qiang Wang; Fu-Shan Xue; Yuan-Jing Yuan; Shan Li; Jian-Hua Liu; Xu Liao; Yan-Ming Zhang
Journal:  Inflamm Res       Date:  2010-12-31       Impact factor: 4.575

Review 6.  Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview.

Authors:  Zohi Sternberg; B Schaller
Journal:  Transl Stroke Res       Date:  2019-07-20       Impact factor: 6.829

7.  Optimal intervention time of vagal stimulation attenuating myocardial ischemia/reperfusion injury in rats.

Authors:  Qiang Wang; Rui-Ping Li; Fu-Shan Xue; Shi-Yu Wang; Xin-Long Cui; Yi Cheng; Gao-Pu Liu; Xu Liao
Journal:  Inflamm Res       Date:  2014-10-08       Impact factor: 4.575

8.  Effect of noradrenalin and EGb 761 pretreatment on the ischemia-reperfusion injured spinal cord neurons in rabbits.

Authors:  Eva Mechírová; Iveta Domoráková; Marianna Danková; Viera Danielisová; Jozef Burda
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

9.  Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction.

Authors:  Peter E Penson; William R Ford; Emma J Kidd; Kenneth J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

10.  Effect of different doses of noradrenaline against ischemia-induced ventricular arrhythmias in rat heart in vivo.

Authors:  Alireza Imani; Mahdieh Faghihi; Mansoor Keshavarz; Seyed Morteza Karimian; Somayeh Sadeghi Niaraki
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.